372 related articles for article (PubMed ID: 18714371)
1. Noncanonical DNA motifs as transactivation targets by wild type and mutant p53.
Jordan JJ; Menendez D; Inga A; Noureddine M; Bell DA; Resnick MA
PLoS Genet; 2008 Jun; 4(6):e1000104. PubMed ID: 18714371
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor acting in cis enhances WT and mutant p53 transactivation at canonical and noncanonical p53 target sequences.
Menendez D; Inga A; Resnick MA
Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1500-5. PubMed ID: 20080630
[TBL] [Abstract][Full Text] [Related]
3. Potentiating the p53 network.
Menendez D; Inga A; Resnick MA
Discov Med; 2010 Jul; 10(50):94-100. PubMed ID: 20670604
[TBL] [Abstract][Full Text] [Related]
4. Differential transactivation by the p53 transcription factor is highly dependent on p53 level and promoter target sequence.
Inga A; Storici F; Darden TA; Resnick MA
Mol Cell Biol; 2002 Dec; 22(24):8612-25. PubMed ID: 12446780
[TBL] [Abstract][Full Text] [Related]
5. Discrimination of DNA binding sites by mutant p53 proteins.
Thukral SK; Lu Y; Blain GC; Harvey TS; Jacobsen VL
Mol Cell Biol; 1995 Sep; 15(9):5196-202. PubMed ID: 7651437
[TBL] [Abstract][Full Text] [Related]
6. Transactivation specificity is conserved among p53 family proteins and depends on a response element sequence code.
Ciribilli Y; Monti P; Bisio A; Nguyen HT; Ethayathulla AS; Ramos A; Foggetti G; Menichini P; Menendez D; Resnick MA; Viadiu H; Fronza G; Inga A
Nucleic Acids Res; 2013 Oct; 41(18):8637-53. PubMed ID: 23892287
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the Influence of a G-Quadruplex Prone Sequence on the Transactivation Potential by Wild-Type and/or Mutant P53 Family Proteins through a Yeast-Based Functional Assay.
Monti P; Brazda V; Bohálová N; Porubiaková O; Menichini P; Speciale A; Bocciardi R; Inga A; Fronza G
Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33672023
[TBL] [Abstract][Full Text] [Related]
8. p53 transactivation and the impact of mutations, cofactors and small molecules using a simplified yeast-based screening system.
Andreotti V; Ciribilli Y; Monti P; Bisio A; Lion M; Jordan J; Fronza G; Menichini P; Resnick MA; Inga A
PLoS One; 2011; 6(6):e20643. PubMed ID: 21674059
[TBL] [Abstract][Full Text] [Related]
9. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.
Inga A; Resnick MA
Oncogene; 2001 Jun; 20(26):3409-19. PubMed ID: 11423991
[TBL] [Abstract][Full Text] [Related]
10. Roles of p53 Family Structure and Function in Non-Canonical Response Element Binding and Activation.
Cai BH; Chao CF; Huang HC; Lee HY; Kannagi R; Chen JY
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357595
[TBL] [Abstract][Full Text] [Related]
11. Probing the functional impact of sequence variation on p53-DNA interactions using a novel microsphere assay for protein-DNA binding with human cell extracts.
Noureddine MA; Menendez D; Campbell MR; Bandele OJ; Horvath MM; Wang X; Pittman GS; Chorley BN; Resnick MA; Bell DA
PLoS Genet; 2009 May; 5(5):e1000462. PubMed ID: 19424414
[TBL] [Abstract][Full Text] [Related]
12. The biological impact of the human master regulator p53 can be altered by mutations that change the spectrum and expression of its target genes.
Menendez D; Inga A; Resnick MA
Mol Cell Biol; 2006 Mar; 26(6):2297-308. PubMed ID: 16508005
[TBL] [Abstract][Full Text] [Related]
13. HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter.
Stros M; Ozaki T; Bacikova A; Kageyama H; Nakagawara A
J Biol Chem; 2002 Mar; 277(9):7157-64. PubMed ID: 11748232
[TBL] [Abstract][Full Text] [Related]
14. Evolution of p53 transactivation specificity through the lens of a yeast-based functional assay.
Lion M; Raimondi I; Donati S; Jousson O; Ciribilli Y; Inga A
PLoS One; 2015; 10(2):e0116177. PubMed ID: 25668429
[TBL] [Abstract][Full Text] [Related]
15. Crystal structures of the DNA-binding domain tetramer of the p53 tumor suppressor family member p73 bound to different full-site response elements.
Ethayathulla AS; Nguyen HT; Viadiu H
J Biol Chem; 2013 Feb; 288(7):4744-54. PubMed ID: 23243311
[TBL] [Abstract][Full Text] [Related]
16. Functionally distinct polymorphic sequences in the human genome that are targets for p53 transactivation.
Tomso DJ; Inga A; Menendez D; Pittman GS; Campbell MR; Storici F; Bell DA; Resnick MA
Proc Natl Acad Sci U S A; 2005 May; 102(18):6431-6. PubMed ID: 15843459
[TBL] [Abstract][Full Text] [Related]
17. P53 family members modulate the expression of PRODH, but not PRODH2, via intronic p53 response elements.
Raimondi I; Ciribilli Y; Monti P; Bisio A; Pollegioni L; Fronza G; Inga A; Campomenosi P
PLoS One; 2013; 8(7):e69152. PubMed ID: 23861960
[TBL] [Abstract][Full Text] [Related]
18. Analysis of p53 transactivation through high-affinity binding sites.
Chumakov AM; Miller CW; Chen DL; Koeffler HP
Oncogene; 1993 Nov; 8(11):3005-11. PubMed ID: 8414502
[TBL] [Abstract][Full Text] [Related]
19. p53 oligomerization and DNA looping are linked with transcriptional activation.
Stenger JE; Tegtmeyer P; Mayr GA; Reed M; Wang Y; Wang P; Hough PV; Mastrangelo IA
EMBO J; 1994 Dec; 13(24):6011-20. PubMed ID: 7813439
[TBL] [Abstract][Full Text] [Related]
20. A p53-type response element in the GDF15 promoter confers high specificity for p53 activation.
Osada M; Park HL; Park MJ; Liu JW; Wu G; Trink B; Sidransky D
Biochem Biophys Res Commun; 2007 Mar; 354(4):913-8. PubMed ID: 17276395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
